SCHEMBL4924733

SCHEMBL4924733

CC(C)(C)P(C)(=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.52
ESR1 P03372 1/20 0.46
ALDH1A1 P00352 4/20 0.45
GAA P10253 3/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
PKM P14618 1/20 0.45
CA2 P00918 1/20 0.44
CA4 P22748 1/20 0.44
CA5A P35218 1/20 0.44
NPSR1 Q6W5P4 2/20 0.43
MAPT P10636 3/20 0.42
HPGD P15428 2/20 0.42
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.40
CFTR P13569 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
ALPG P10696 1/20 0.38
ALOX12 P18054 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13010426 1.00 TSHR (0.52) TSHRESR1ALDH1A1GAAMEN1
SCHEMBL15711851 1.00 TSHR (0.52) TSHRESR1ALDH1A1GAAMEN1
SCHEMBL11228761 0.77 TSHR (0.54) TSHRESR1ALDH1A1GAAMEN1
SCHEMBL6150967 0.77 TSHR (0.54) TSHRESR1ALDH1A1GAAMEN1
SCHEMBL115791 0.75 ESR1 (0.71) TSHRESR1ALDH1A1GAAMEN1
SCHEMBL14246523 0.73 TSHR (0.50) TSHRESR1ALDH1A1GAAMEN1
SCHEMBL15256262 0.73 TSHR (0.50) TSHRESR1ALDH1A1GAAMEN1
SCHEMBL4879440 0.73 TSHR (0.55) TSHRESR1ALDH1A1GAAMEN1
SCHEMBL5454368 0.73 TSHR (0.50) TSHRESR1ALDH1A1GAAMEN1
SCHEMBL25435946 0.73 ESR1 (0.68) TSHRESR1ALDH1A1GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212204-A1 REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS THE SCRIPPS RESEARCH INSTITUTE 2023-07-06 US disclosed
US-20200407381-A1 C-BULKY P-CHIROGENIC ORGANOPHOSPHORUS COMPOUNDS Université de Bourgogne (FR) 2020-12-31 US disclosed
CN-111868065-A C-sterically hindered P-chirally derived organophosphorus compounds 勃艮第大学 2020-10-30 CN disclosed
EP-2920189-B1 PROCESS FOR MAKING NOVEL CHIRAL PHOSPHORUS LIGANDS BOEHRINGER INGELHEIM INT (DE) 2017-08-02 EP disclosed
US-8471067-B2 Stereoselective preparation of P-chiral four-co-ordinated phosphorus compound (o-Tolylphenylmethylphosphine oxide) by reacting chiral alcohol, chiral amine or chiral thiol, with P-chiral three-co-ordinated phosphorus compound, in presence of electrophile UNIVERSITY COLLEGE DUBLIN (IE) 2013-06-25 US disclosed
US-20080255391-A1 Chiral Phosphorus Compounds UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND (IE) 2008-10-16 US disclosed
EP-1751170-A1 CHIRAL PHOSPHORUS COMPOUNDS UNIVERSITY COLLEGE DUBLIN (IE) 2007-02-14 EP disclosed
WO-2005118603-A1 CHIRAL PHOSPHORUS COMPOUNDS UNIVERSITY COLLEGE DUBLIN (IE) 2005-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200407381-A1 C-BULKY P-CHIROGENIC ORGANOPHOSPHORUS COMPOUNDS PLCG1, PLCG2, ACHE TSHR 3498/4885ESR1 3791/4885ALDH1A1 3679/4885
US-20080255391-A1 Chiral Phosphorus Compounds PHOSPHO1, PNKP, PTMS TSHR 2680/4885ESR1 2438/4885ALDH1A1 612/4885
US-20230212204-A1 REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS PNKP, POLL, RNGTT TSHR 3568/4885ESR1 3274/4885ALDH1A1 3938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.